Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 1,000

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis

Open access
Buitrago-Garcia, Diana, Egli-Gany, Dianne, Counotte, Michel J., Hossmann, Stefanie, Imeri, Hira, Ipekci, Aziz Mert, Salanti, Georgia, Low, Nicola · 2020 · PLOS Medicine

Published version of a preprint

Abstract

BACKGROUND There is disagreement about the level of asymptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. We conducted a living systematic review and meta-analysis to address three questions: 1. amongst people who become infected with SARS-CoV-2, what proportion does not experience symptoms at all during their infection? 2. Amongst people with SARS-CoV-2 infection who are asymptomatic when diagnosed, what proportion will develop symptoms later? 3. What proportion of SARS-CoV-2 transmission is accounted for by people who are either asymptomatic throughout infection, or pre-symptomatic? METHODS AND FINDINGS We searched PubMed, Embase, bioRxiv and medRxiv using a database of SARS-CoV-2 literature that is updated daily, on 25 March 2020, 20 April 2020 and 10 June 2020. Studies of people with SARS-CoV-2 diagnosed by reverse transcriptase PCR that documented follow-up and symptom status at the beginning and end of follow-up, or modelling studies were included. One reviewer extracted data and a second verified the extraction, with disagreement resolved by discussion or a third reviewer. Risk of bias in empirical studies was assessed with an adapted checklist for case series and the relevance and credibility of modelling studies were assessed using a published checklist. We included a total of 94 studies. The overall estimate of the proportion of people who become infected with SARS-CoV-2 and remain asymptomatic throughout infection was 20% (95% CI 17-25) with a prediction interval of 3-67% in 79 studies that addressed this review question. There was some evidence that biases in the selection of participants influence the estimate. In seven studies of defined populations screened for SARS-CoV-2 and then followed, 31% (95% CI 26-37%, prediction interval 24-38%) remained asymptomatic. The proportion of people that is pre-symptomatic could not be summarised, owing to heterogeneity. The secondary attack rate was slightly lower in contacts of people with asymptomatic infection than those with symptomatic infection (relative risk 0.35, 95% CI 0.10-1.27). Modelling studies fit to data found a higher proportion of all SARS-CoV-2 infections resulting from transmission from pre-symptomatic individuals than from asymptomatic individuals. Limitations of the review include that most included studies were not designed to estimate the proportion of asymptomatic SARS-CoV-2 infections and were at risk of selection biases, we did not consider the possible impact of false negative RT-PCR results, which would underestimate the proportion of asymptomatic infections, and that the database does not include all sources. CONCLUSIONS The findings of this living systematic review of publications early in the pandemic suggest that most SARS-CoV-2 infections are not asymptomatic throughout the course of infection. The contribution of pre-symptomatic and asymptomatic infections to overall SARS-CoV-2 transmission means that combination prevention measures, with enhanced hand hygiene, masks, testing tracing and isolation strategies and social distancing, will continue to be needed. AUTHOR SUMMARY Why was this study done? ▪ The proportion of people who will remain asymptomatic throughout the course of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (covid-19), is not known. ▪ Studies that assess people at just one time point will overestimate the proportion of true asymptomatic infection because those who go on to develop covid-19 symptoms will be wrongly classified as asymptomatic, rather than pre-symptomatic. ▪ The amount, and infectiousness, of asymptomatic SARS-CoV-2 infection will determine what kind of measures will prevent transmission most effectively. What did the researchers do and find? ▪ We did a living systematic review through 10 June 2020, using automated workflows that speed up the review processes, and allow the review to be updated when relevant new evidence becomes available. ▪ Overall, in 79 studies in a range of different settings, 20% (95% confidence interval, CI 17–25%) of people with SARS-CoV-2 infection remained asymptomatic during follow-up, but biases in study designs limit the certainty of this estimate. ▪ We found some evidence that SARS-CoV-2 infection in contacts of people with asymptomatic infection is less likely than in contacts of people with symptomatic infection (relative risk 0.35, 95% CI 0.10-1.27). What do these findings mean? ▪ The findings of this living systematic review suggest that most SARS-CoV-2 infections are not asymptomatic throughout the course of infection. ▪ Future studies should be designed specifically to determine the true proportion of asymptomatic SARS-CoV-2 infections, using methods to minimise biases in the selection of study participants and ascertainment of symptom status during follow up. ▪ The contribution of pre-symptomatic and asymptomatic infections to overall SARS-CoV-2 trans

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1003346

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 31

  1. 2017, Rapid Reviews to Strengthen Health Policy and Systems: A Practical Guide
  2. Buitrago-Garcia D, Egli-Gany D, Counotte M, Hossmann S, Imeri H, Salanti G, et al. The Role of Asymptomatic Sars-Cov-2 Infections: Rapid Living Systematic Review and Meta-Analysis. Version 1. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. Available from: https://doi.org/10.1101/2020.04.25.20079103 · DOI
  3. Buitrago-Garcia D, Egli-Gany D, Counotte M, Hossmann S, Imeri H, Salanti G, et al. The Role of Asymptomatic Sars-Cov-2 Infections: Rapid Living Systematic Review and Meta-Analysis. Version 2. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. Available from: https://doi.org/10.1101/2020.04.25.20079103 · DOI
  4. M Counotte, 2020, Covid-19 Living Evidence. Bern: Institute of Social and Preventive Medicine
  5. JF Chan, 2019, Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster, Lancet, 395, 514
  6. SH Luo, 2020, A Confirmed Asymptomatic Carrier of 2019 Novel Coronavirus, Chin Med J (Engl), 133, 1123, 10.1097/CM9.0000000000000798 · doi:10.1097/cm9.0000000000000798
  7. Tabata S, Imai K, Kawano S, Ikeda M, Kodama T, Miyoshi K, et al. Non-Severe Vs Severe Symptomatic Covid-19: 104 Cases from the Outbreak on the Cruise Ship 'Diamond Princess' in Japan. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.03.18.20038125 · DOI
  8. Luo L, Liu D, Liao X-l, Wu X-b, Jing Q-l, Zheng J-z, et al. Modes of Contact and Risk of Transmission in Covid-19 among Close Contacts. bioRxiv [Preprint]. 2020 [cited 2020 Jul 27]. Available from: https://www.medrxiv.org/content/10.1101/2020.03.24.20042606v1 · DOI
  9. KC See, 2020, Covid-19: Four Paediatric Cases in Malaysia, Int J Infect Dis, 94, 125, 10.1016/j.ijid.2020.03.049 · DOI
  10. Tian S, Wu M, Chang Z, Wang Y, Zhou G, Zhang W, et al. Epidemiological Investigation and Intergenerational Clinical Characteristics of 24 Covid-19 Patients Associated with Supermarket Cluster. bioRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.04.11.20058891 · doi:10.1101/2020.04.11.20058891
  11. Y Wang, 2020, Clinical Outcome of 55 Asymptomatic Cases at the Time of Hospital Admission Infected with Sars-Coronavirus-2 in Shenzhen, China, J Infect Dis
  12. HO Al-Shamsi, 2020, Screening for Covid-19 in Asymptomatic Patients with Cancer in a Hospital in the United Arab Emirates, JAMA Oncol
  13. K Bai, 2020, Clinical Analysis of 25 Novel Coronavirus Infections in Children, Pediatr Infect Dis J
  14. Casey M, Griffin J, McAloon CG, Byrne AW, Madden JM, McEvoy D, et al. Estimating Pre-Symptomatic Transmission of Covid-19: A Secondary Analysis Using Published Data. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.08.20094870 · DOI
  15. Chang MC, Hur J, Park D. Chest Computed Tomography Findings in Asymptomatic Patients with Covid-19. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.09.20096370 · doi:10.1101/2020.05.09.20096370
  16. Y Gao, 2020, A Cluster of the Corona Virus Disease 2019 Caused by Incubation Period Transmission in Wuxi, China, J Infect
  17. L Huang, 2020, Initial Ct Imaging Characters of an Imported Family Cluster of Covid-19, Clin Imaging
  18. R Huang, 2020, A Family Cluster of Covid-19 Involving an Asymptomatic Case with Persistently Positive Sars-Cov-2 in Anal Swabs, Travel Med Infect Dis
  19. XL Jiang, 2020, Transmission Potential of Asymptomatic and Paucisymptomatic Sars-Cov-2 Infections: A Three-Family Cluster Study in China, J Infect Dis
  20. W Kong, 2020, Comparison of Clinical and Epidemiological Characteristics of Asymptomatic and Symptomatic Sars-Cov-2 Infection: A Multi-Center Study in Sichuan Province, China, Travel Med Infect Dis
  21. Kumar R, Bhattacharya B, Meena VP, Aggarwal A, Tripathi M, Soneja M, et al. Management of Mild Covid-19: Policy Implications of Initial Experience in India. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.20.20107664 · doi:10.1101/2020.05.20.20107664
  22. Y Luo, 2020, Asymptomatic Sars-Cov-2 Infection in Household Contacts of a Healthcare Provider, Wuhan, China, Emerg Infect Dis
  23. Y Ma, 2020, Characteristics of Asymptomatic Patients with Sars-Cov-2 Infection in Jinan, China. Microbes Infect
  24. X Tan, 2020, Clinical Features of Children with Sars-Cov-2 Infection: An Analysis of 13 Cases from Changsha, China, Zhongguo Dang Dai Er Ke Za Zhi
  25. Pham TQ, Rabaa MA, Duong LH, Dang TQ, Tran QD, Quach HL, et al. The First 100 Days of Sars-Cov-2 Control in Vietnam. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.12.20099242 · doi:10.1101/2020.05.12.20099242
  26. Y Wang, 2020, Characterization of an Asymptomatic Cohort of Sars-Cov-2 Infected Individuals Outside of Wuhan, China, Clin Infect Dis
  27. HP Wu, 2020, Clinical Features of Coronavirus Disease 2019 in Children Aged <18 Years in Jiangxi, China: An Analysis of 23 Cases, Zhongguo Dang Dai Er Ke Za Zhi, 22, 419
  28. Xu H, Liu E, Xie J, Smyth R, Zhou Q, Zhao R, et al. A Follow-up Study of Children Infected with Sars-Cov-2 from Western China. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.04.20.20073288 · doi:10.1101/2020.04.20.20073288
  29. Zhang W, Long Q, Huang Y, Chen C, Wu J, Hong Y, et al. Asymptomatic Covid-19 Have Longer Treatment Cycle Than Moderate Type of Confirmed Patients. medRxiv [Preprint]. 2020 [cited 2020 Jul 27]. doi: 10.1101/2020.05.16.20103796 · doi:10.1101/2020.05.16.20103796
  30. NVV Chau, 2020, The Natural History and Transmission Potential of Asymptomatic Sars-Cov-2 Infection, Clin Infect Dis
  31. C Heneghan, 2020, Covid-19: What Proportion Are Asymptomatic?

Cited by

See all 1,000

Metadata

Authors
Buitrago-Garcia, D., Egli-Gany, D., Counotte, M. J., Hossmann, S., Imeri, H., Ipekci, A. M., Salanti, G., & Low, N.
Venue
PLOS Medicine
Published
2020-09-22
Volume
17
Issue
9
Pages
e1003346
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W3087248341
Cited by
1,000
References
111
FWCI
8.52
Type
journal article
Language
en
Open access
gold
Funders
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (320030_176233)
  • European Union Horizon 2020 research and innovation programme (101003688)
  • Swiss Government Excellence Scholarship (2019.0774)
  • Swiss School of Public Health plus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.